• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

南美洲首例在Cyp51Ap中发生G54E替代的对伊曲康唑耐药的烟曲霉临床分离株。

First itraconazole resistant Aspergillus fumigatus clinical isolate harbouring a G54E substitution in Cyp51Ap in South America.

作者信息

Leonardelli Florencia, Theill Laura, Nardin María Elena, Macedo Daiana, Dudiuk Catiana, Mendez Emilce, Gamarra Soledad, Garcia-Effron Guillermo

机构信息

Laboratorio de Micología y Diagnóstico Molecular - Cátedra de Parasitología y Micología - Facultad de Bioquímica y Ciencias Biológicas, Universidad Nacional del Litoral, Santa Fe, Argentina; Consejo Nacional de Investigaciones Científicas y Tecnológicas (CONICET), CCT- Santa Fe, Argentina.

Laboratorio de Micología y Diagnóstico Molecular - Cátedra de Parasitología y Micología - Facultad de Bioquímica y Ciencias Biológicas, Universidad Nacional del Litoral, Santa Fe, Argentina.

出版信息

Rev Iberoam Micol. 2017 Jan-Mar;34(1):46-48. doi: 10.1016/j.riam.2016.05.005. Epub 2017 Jan 10.

DOI:10.1016/j.riam.2016.05.005
PMID:28087293
Abstract

BACKGROUND

A 27-year-old male rural worker was admitted with a fungal keratitis due to an injury involving plant detritus.

MATERIALS AND METHODS

Specimens were collected for microscopy examination and culture. The isolate was identified by morphological and molecular criteria. Susceptibility testing was performed using CLSI methods. CYP51A gene was PCR amplified and sequenced.

RESULTS

An Aspergillus fumigatus strain resistant to itraconazole (MIC>8μg/ml) was isolated. The isolate was susceptible to amphotericin B, posaconazole, voriconazole and caspofungin. CYP51A sequencing showed two mutations leading on the G54E substitution. The patient received natamycin as treatment.

CONCLUSIONS

This is the first report in South America of a clinical A. fumigatus strain carrying the substitution G54E at Cyp51Ap associated with itraconazole resistance. Considering the patient was azole-naive, this resistant isolate may have been acquired from the environment.

摘要

背景

一名27岁的男性农民工因涉及植物碎屑的损伤而被收治,诊断为真菌性角膜炎。

材料与方法

采集标本进行显微镜检查和培养。通过形态学和分子标准对分离株进行鉴定。使用CLSI方法进行药敏试验。对CYP51A基因进行PCR扩增和测序。

结果

分离出一株对伊曲康唑耐药(MIC>8μg/ml)的烟曲霉菌株。该分离株对两性霉素B、泊沙康唑、伏立康唑和卡泊芬净敏感。CYP51A测序显示两个导致G54E替代的突变。患者接受那他霉素治疗。

结论

这是南美洲首次报道临床烟曲霉菌株在Cyp51Ap处携带与伊曲康唑耐药相关的G54E替代。考虑到患者未曾使用过唑类药物,这种耐药分离株可能是从环境中获得的。

相似文献

1
First itraconazole resistant Aspergillus fumigatus clinical isolate harbouring a G54E substitution in Cyp51Ap in South America.南美洲首例在Cyp51Ap中发生G54E替代的对伊曲康唑耐药的烟曲霉临床分离株。
Rev Iberoam Micol. 2017 Jan-Mar;34(1):46-48. doi: 10.1016/j.riam.2016.05.005. Epub 2017 Jan 10.
2
First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey.在土耳其首次测定携带TR34/L98H突变的烟曲霉菌株对唑类药物的耐药性。
J Infect Chemother. 2015 Aug;21(8):581-6. doi: 10.1016/j.jiac.2015.04.012. Epub 2015 May 14.
3
Aspergillus fumigatus harbouring the sole Y121F mutation shows decreased susceptibility to voriconazole but maintained susceptibility to itraconazole and posaconazole.烟曲霉仅携带 Y121F 突变时对伏立康唑的敏感性降低,但对伊曲康唑和泊沙康唑的敏感性保持不变。
J Antimicrob Chemother. 2014 Dec;69(12):3244-7. doi: 10.1093/jac/dku316. Epub 2014 Aug 13.
4
Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma.从一名肺曲菌球患者连续分离出的烟曲霉中cyp51A基因的突变及其对伊曲康唑的敏感性
J Antimicrob Chemother. 2005 Jan;55(1):31-7. doi: 10.1093/jac/dkh507. Epub 2004 Nov 24.
5
Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies.在法国血液恶性肿瘤患者接受治疗的队列中,烟曲霉对唑类药物的耐药率较低。
J Antimicrob Chemother. 2011 Feb;66(2):371-4. doi: 10.1093/jac/dkq450. Epub 2010 Dec 5.
6
Establishing in vitro-in vivo correlations for Aspergillus fumigatus: the challenge of azoles versus echinocandins.建立烟曲霉的体外-体内相关性:唑类药物与棘白菌素类药物面临的挑战
Antimicrob Agents Chemother. 2008 Oct;52(10):3504-11. doi: 10.1128/AAC.00190-08. Epub 2008 Jul 21.
7
The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus.cdr1B 外排转运蛋白与烟曲霉中非 Cyp51a 介导的伊曲康唑耐药性相关。
J Antimicrob Chemother. 2013 Jul;68(7):1486-96. doi: 10.1093/jac/dkt075. Epub 2013 Apr 10.
8
Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014.2010年至2014年从伊朗患者中分离出的烟曲霉TR34/L98H和TR46/Y121F/T289A阳性菌株的单核苷酸多态性定量分析用于快速检测
Antimicrob Agents Chemother. 2015 Nov 2;60(1):387-92. doi: 10.1128/AAC.02326-15. Print 2016 Jan.
9
Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure.烟曲霉中唑类耐药与治疗失败相关的频率及演变
Emerg Infect Dis. 2009 Jul;15(7):1068-76. doi: 10.3201/eid1507.090043.
10
Azole susceptibility in clinical and environmental isolates of Aspergillus fumigatus from eastern Hokkaido, Japan.日本北海道东部烟曲霉临床及环境分离株的唑类药敏性
J Infect Chemother. 2016 Sep;22(9):648-50. doi: 10.1016/j.jiac.2016.03.002. Epub 2016 Apr 2.

引用本文的文献

1
Uncovering a Novel 51A Mutation and Antifungal Resistance in through Culture Collection Screening.通过菌种保藏筛选发现一种新的51A突变及抗真菌耐药性。
J Fungi (Basel). 2024 Feb 1;10(2):122. doi: 10.3390/jof10020122.
2
Reduced Susceptibility to Azoles in Cryptococcus gattii Correlates with the Substitution R258L in a Substrate Recognition Site of the Lanosterol 14-α-Demethylase.隐球菌中唑类药物敏感性降低与 14α-羊毛甾醇去甲基酶底物识别位点的 R258L 取代有关。
Microbiol Spectr. 2023 Aug 17;11(4):e0140323. doi: 10.1128/spectrum.01403-23. Epub 2023 Jun 21.
3
The challenges of the genome-based identification of antifungal resistance in the clinical routine.
临床常规中基于基因组鉴定抗真菌药物耐药性所面临的挑战。
Front Microbiol. 2023 Apr 20;14:1134755. doi: 10.3389/fmicb.2023.1134755. eCollection 2023.
4
Update on diagnosis and management of refractory corneal infections.难治性角膜感染的诊断与治疗进展
Indian J Ophthalmol. 2022 May;70(5):1475-1490. doi: 10.4103/ijo.IJO_2273_21.
5
Population genomics confirms acquisition of drug-resistant Aspergillus fumigatus infection by humans from the environment.人群基因组学证实,人类耐药烟曲霉感染是从环境中获得的。
Nat Microbiol. 2022 May;7(5):663-674. doi: 10.1038/s41564-022-01091-2. Epub 2022 Apr 25.
6
A 20-Year Antifungal Susceptibility Surveillance (From 1999 to 2019) for spp. and Proposed Epidemiological Cutoff Values for and : A Study in a Tertiary Hospital in China.某菌属20年抗真菌药敏监测(1999年至2019年)及该菌属和另一菌属的拟议流行病学截断值:中国一家三级医院的研究
Front Microbiol. 2021 Jul 22;12:680884. doi: 10.3389/fmicb.2021.680884. eCollection 2021.
7
Emergence of Triazole Resistance in spp. in Latin America.拉丁美洲 属中三唑抗性的出现。 (注:原文中“ spp.”表述不完整,可能影响对准确物种的理解)
Curr Fungal Infect Rep. 2021;15(3):93-103. doi: 10.1007/s12281-021-00418-6. Epub 2021 May 19.
8
Dissection of the Activity of Agricultural Fungicides against Clinical Isolates with and without Environmentally and Medically Induced Azole Resistance.农业杀菌剂对有无环境和医学诱导唑类抗性的临床分离株的活性剖析。
J Fungi (Basel). 2021 Mar 11;7(3):205. doi: 10.3390/jof7030205.
9
A Novel Combination of Mutations Confers Pan-Azole Resistance in Aspergillus fumigatus.新型突变组合导致烟曲霉对泛唑类药物的耐药性。
Antimicrob Agents Chemother. 2020 Jul 22;64(8). doi: 10.1128/AAC.02501-19.
10
The fading boundaries between patient and environmental routes of triazole resistance selection in Aspergillus fumigatus.烟曲霉中三唑耐药性选择的患者途径与环境途径之间逐渐模糊的界限。
PLoS Pathog. 2019 Aug 22;15(8):e1007858. doi: 10.1371/journal.ppat.1007858. eCollection 2019 Aug.